No distinction is made in the Ambry reports about comparing mosaic and non-mosaic frequencies of NF1 variants.1–3 Indeed it might be expected that mosaic involvement of NF1 would be less likely to result in breast cancer and this was reflected by an older age at testing of 67 years compared to 49 years for constitutional cases.14 This evidence concerns the gene NF1 and breast cancer.